Evaluating adherence to guidelines for managing dyslipidemia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses how well healthcare providers comply with European and French guidelines for managing dyslipidemia in hospitalized patients. It focuses on patients aged over 18 who have been admitted for at least 24 hours and have had blood samples taken to measure lipid levels. The study aims to identify gaps in adherence to guidelines and improve the management of dyslipidemia, which is a significant risk factor for cardiovascular diseases. By analyzing patient data, the study seeks to enhance treatment strategies and outcomes for individuals with dyslipidemia.

Why it matters

Who can join: the full rules

Inclusion criteria:

\- Patients aged above 18 years old, admitted to the department during the study period and hospitalized for at least 24 hours, blood samples taken within 24 hours of hospitalization admission (LDL-C, triglycerides)

Exclusion criteria:

\- Patients with elevated triglycerides (\>4.5 mmol/L or \>400 mg/dL)

Where it's running

• Uhmontpellier
  Montpellier, France Recruiting

Study contacts

• Principal investigator: Cyril BREUKER — University Hospital, Montpellier
• Study coordinator: Cyril BREUKER, PharmD,Phd
• Email: c-breuker@chu-montpellier.fr
• Phone: 467337121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Islet re-transplantation after prior graft failure in adults with type 1 diabetes

  This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07666789

• Tissue models of systemic sclerosis using patient-derived iPSCs

  Researchers will create iPSC lines from people with systemic sclerosis, their healthy relatives, and test them across several cell types to see how the disease affects tissues in the lab.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07650565

• L-dopa treatment for a CTNNB1-related neurodevelopmental disorder in children

  This study tests whether L-dopa can help children with a CTNNB1-related neurodevelopmental disorder who have dystonia.

  Recruiting University Hospital, Montpellier · Montpellier, Hérault · NCT07614126

• Exploratory look at brain blood flow and metabolism before and after removing unruptured AVMs

  This study tests brain perfusion and metabolism with PET imaging and neuropsychological tests in adults before and six months after surgical treatment for unruptured brain AVMs.

  Recruiting University Hospital, Montpellier · Montpellier, France · NCT07569887

• Immun4Cure Cohort of Autoimmune Diseases

  A long-term, 500-person database and biobank is being built to study autoimmune diseases like RA, SLE, and scleroderma, plus healthy adults, using deep profiling and regular follow-ups over five years.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07515638

• Comparing supra-annular versus intra-annular self-expanding aortic valves in routine TAVR practice

  This project will try to see if the supra‑annular Evolut valve or the intra‑annular Navitor valve gives better one‑month procedural success and six‑month clinical and echocardiographic results for patients receiving TAVR with self‑expanding devices.

  Recruiting University Hospital, Montpellier · Montpellier, Occitanie · NCT07506382

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.